Please wait a minute...
Reviews in Cardiovascular Medicine  2021, Vol. 22 Issue (1): 11-24     DOI: 10.31083/j.rcm.2021.01.134
Special Issue: Heart failure pathogenesis and management: heart failure with preserved ejection fraction
Review Previous articles | Next articles
Imaging in heart failure with preserved ejection fraction: insights into echocardiography and cardiac magnetic resonance imaging
Martin A. Chacon-Portillo1, Tushar Acharya1, 2, Rajesh Janardhanan1, 2, *()
1Department of Internal Medicine, University of Arizona College of Medicine, Tucson, AZ 85724, USA
2Division of Cardiology, Sarver Heart Center, University of Arizona College of Medicine, Tucson, AZ 85724, USA
Download:  PDF(1455KB)  ( 1186 ) Full text   ( 265 )
Export:  BibTeX | EndNote (RIS)      
Abstract:
Heart failure with preserved ejection fraction (HFpEF) is increasingly prevalent and represents more than half of all heart failure cases. It is defined by the presence of heart failure signs and symptoms, identification of cardiac structural abnormalities leading to high left ventricular filling pressures, and an EF > 50%. Common imaging findings in HFpEF include left ventricular hypertrophy, diastolic dysfunction, left atrial enlargement, and elevated pulmonary artery pressure (> 35 mm Hg). Echocardiography is the primary imaging modality for diagnosing HFpEF. It can be complemented by cardiac magnetic resonance (CMR) when further characterization is needed. Advances like real-time 3-dimensional echocardiography and speckle-tracking derived strain, as well as tissue characterization by CMR, have furthered our understanding of the mechanisms and aided in making the diagnosis of a diverse group of conditions that can present as HFpEF. This review aims to touch upon the imaging methods of characterizing HFpEF and discuss their role in specific disease entities.
Key words:  Heart failure      Ejection fraction      Left ventricular hypertrophy      Echocardiography      Cardiac magnetic resonance     
Submitted:  13 July 2020      Revised:  28 December 2020      Accepted:  29 December 2020      Published:  30 March 2021     
*Corresponding Author(s):  Rajesh Janardhanan     E-mail:  raj@shc.arizona.edu

Cite this article: 

Martin A. Chacon-Portillo, Tushar Acharya, Rajesh Janardhanan. Imaging in heart failure with preserved ejection fraction: insights into echocardiography and cardiac magnetic resonance imaging. Reviews in Cardiovascular Medicine, 2021, 22(1): 11-24.

URL: 

https://rcm.imrpress.com/EN/10.31083/j.rcm.2021.01.134     OR     https://rcm.imrpress.com/EN/Y2021/V22/I1/11

[1] Luca Di Lullo, Antonio Bellasi, Vincenzo Barbera, Claudio Ronco. Cardionephrology and cardiorenal disease in Italy: state of the art[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 563-572.
[2] Hongbo Gan, Heng Tang, Yujie Huang, Dan Wang, Peng Pu, Zhong Zuo. The 'diamond' approach to personalized drug treatment of heart failure with reduced ejection fraction[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 573-584.
[3] Ronald O. Morales, Francesc Barbosa, Nuria Farre. Peritoneal dialysis in heart failure: focus on kidney and ventricular dysfunction[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 649-657.
[4] Matteo Beltrami, Simone Bartolini, Massimo Milli, Alberto Palazzuoli. The relevance of specific heart failure outpatient programs in the COVID era: an appropriate model for every disease[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 677-690.
[5] Roger E Peverill. Changes in left ventricular size, geometry, pump function and left heart pressures during healthy aging[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 717-729.
[6] Sarah Fitzsimons, Robert N Doughty. Role of transthoracic echocardiogram in acute heart failure[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 741-754.
[7] Martha Kyriakou, Anastasia Samara, Katerina Philippou, Ioanna Lakatamitou, Ekaterini Lambrinou. A qualitative meta-synthesis of patients with heart failure perceived needs[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 853-864.
[8] Yaowang Lin, Yang Chen, Jie Yuan, Xinli Pang, Huadong Liu, Shaohong Dong, Qiuling Chen. Intravenous morphine use in acute heart failure increases adverse outcomes: a meta-analysis[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 865-872.
[9] Christos Papageorgiou, Eleftheria Tsagalou, Ioannis Baraboutis, Konstantinos Tampakis, Efstathios Kastritis, Meletios-Athanasios Dimopoulos. Cardiac amyloidosis presenting with coronary artery embolization[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 883-889.
[10] Ali Yazdanyar, Muhammad Haisum Maqsood, Jerald Pelayo, Julien Sanon, Eduardo Quintero, Kevin Bryan Lo, Roy O. Mathew, Janani Rangaswami. Clinical outcomes in patients with heart failure with and without cirrhosis: an analysis from the national inpatient sample[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 925-929.
[11] Janani Rangaswami. Closing gaps in the care of patients with heart-kidney disease: the time is now[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 257-258.
[12] Melanie McGinlay, Sam Straw, Jacob Jagger, Bako Nouri, John Gierula, Klaus K Witte. Impact of the COVID-19 pandemic on the management of chronic heart failure[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 271-276.
[13] Agata Bielecka-Dabrowa, Anna Cichocka-Radwan, Joanna Lewek, Filip Pawliczak, Marek Maciejewski, Maciej Banach. Cardiac manifestations of COVID-19[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 365-371.
[14] Paulino Alvarez, Alex Sianis, Jessica Brown, Abbas Ali, Alexandros Briasoulis. Chronic disease management in heart failure: focus on telemedicine and remote monitoring[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 403-413.
[15] Catrin Sohrabi, Syed Ahsan, Alexandros Briasoulis, Emmanuel Androulakis, Gerasimos Siasos, Neil T Srinivasan, Nikolaos Papageorgiou. Contemporary management of heart failure patients with reduced ejection fraction: the role of implantable devices and catheter ablation[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 415-428.
No Suggested Reading articles found!